Ariza, Ermelinda C.

HRN: 28-21-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2025
CEFTRIAXONE 1G (VIAL)
12/05/2025
12/11/2025
IV
2g
OD
Cap-MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines